Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Herbert

Showing results (581-590 of 657) with videos related to

Pageof 66
Sort By:
Cancer|April 1, 1995
Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorptionL M Cher, F H Hochberg, J Teruya, et al.
European Journal of Biochemistry|July 1, 1994
Rat platelets contain glycosylated and non-glycosylated forms of platelet factor 4. Identification and characterization by mass spectrometryC Ravanat, C Gachet, J M Herbert, et al.
Journal of Cardiovascular Pharmacology|August 7, 2001
Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient miceF Dol, G Martin, B Staels, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1997
Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopeniaJ Amiral, J C Lormeau, A Marfaing-Koka, et al.
Journal of the American College of Cardiology|March 1, 1995
Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) InvestigatorsR F Davies, H Habibi, W P Klinke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1996
Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activationM Humbert, P Nurden, C Bihour, et al.
The Journal of Physical Chemistry. A|November 12, 2010
Noncovalent interactions in extended systems described by the effective fragment potential method: theory and application to nucleobase oligomersDebashree Ghosh, Dmytro Kosenkov, Vitalii Vanovschi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 6, 2001
Experimental proof for the structure of a thrombin-inhibiting heparin moleculeM Petitou, A Imberty, P Duchaussoy, et al.
Carbohydrate Research|August 31, 1999
Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibitionP Duchaussoy, G Jaurand, P A Driguez, et al.
Frontiers in Molecular Biosciences|October 24, 2022
Smooth muscle Acid-sensing ion channel 1a as a therapeutic target to reverse hypoxic pulmonary hypertensionSelina M Garcia, Tracy R Yellowhair, Neil D Detweiler, et al.
Pageof 66

Showing results (581-590 of 657) with videos related to

Sort By:
Pageof 66
Cancer|April 1, 1995
Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorptionL M Cher, F H Hochberg, J Teruya, et al.
European Journal of Biochemistry|July 1, 1994
Rat platelets contain glycosylated and non-glycosylated forms of platelet factor 4. Identification and characterization by mass spectrometryC Ravanat, C Gachet, J M Herbert, et al.
Journal of Cardiovascular Pharmacology|August 7, 2001
Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient miceF Dol, G Martin, B Staels, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1997
Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopeniaJ Amiral, J C Lormeau, A Marfaing-Koka, et al.
Journal of the American College of Cardiology|March 1, 1995
Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) InvestigatorsR F Davies, H Habibi, W P Klinke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1996
Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activationM Humbert, P Nurden, C Bihour, et al.
The Journal of Physical Chemistry. A|November 12, 2010
Noncovalent interactions in extended systems described by the effective fragment potential method: theory and application to nucleobase oligomersDebashree Ghosh, Dmytro Kosenkov, Vitalii Vanovschi, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 6, 2001
Experimental proof for the structure of a thrombin-inhibiting heparin moleculeM Petitou, A Imberty, P Duchaussoy, et al.
Carbohydrate Research|August 31, 1999
Assessment through chemical synthesis of the size of the heparin sequence involved in thrombin inhibitionP Duchaussoy, G Jaurand, P A Driguez, et al.
Frontiers in Molecular Biosciences|October 24, 2022
Smooth muscle Acid-sensing ion channel 1a as a therapeutic target to reverse hypoxic pulmonary hypertensionSelina M Garcia, Tracy R Yellowhair, Neil D Detweiler, et al.
Pageof 66